Peer-Reviewed Journal Details
Mandatory Fields
Hayes, P,Casey, M,Glynn, LG,Molloy, GJ,Durand, H,O'Brien, E,Dolan, E,Das, K,Newell, J,Finn, D,Harhen, B,Conneely, A,Murphy, AW
2019
September
British Journal Of General Practice
Measuring adherence to therapy in apparent treatment resistant hypertension: a feasibility study in Irish primary care
Published
Optional Fields
hypertension primary care pseudo-resistance treatment adherence urinalysis BLOOD-PRESSURE PHARMACOKINETICS NONADHERENCE
69
621
628
BackgroundApparent treatment-resistant hypertension (aTRH) is defined as uncontrolled blood pressure (BPI in patients taking three or more antihypertensive medications. Some patients will have true treatment resistant hypertension. some undiagnosed secondary hypertension, while others have pseudo-resistance. Pseudo-resistance occurs when non-adherence to medication, white-coat hypertension NCH), lifestyle, and inadequate drug dosing are responsible for the poorly controlled BP.AimTo examine the feasibility of establishing non-adherence to medication, for the first time in primary care, using mass spectrometry urine analysis. Operationalisation would be established by at least 50% of patients participating and 95% of samples being suitable for analysis. Clinical importance would be confirmed by >10% of patients being non-adherent.Design and settingEligible patients with aTRH (n = 453) in 15 university research-affiliated Irish general practices were invited to participate.MethodParticipants underwent mass spectrometry urine analysis to test adherence and ambulatory BP monitoring (ABPM) to examine WCH.ResultsOf the eligible patients invited, 52% (n= 235) participated. All 235 urine samples (100%) were suitable for analysis: 174(74%) patients were fully adherent. 56(24%) partially adherent. and five (2%) fully non-adherent to therapy. A total of 206 patients also had ABPM, and in total 97(45%) were categorised as pseudo-resistant. No significant associations were found between adherence status and patient characteristics or drug class.ConclusionIn patients with aTRH. the authors have established that it is feasible to examine non-adherence to medications using mass spectrometry urine analysis. One in four patients were found to be partially or fully non-adherent. Further research on how to incorporate this approach into individual patient consultations and its associated cost-effectiveness is now appropriate.
10.3399/bjgp19X705077
Grant Details
Publication Themes